Pharmacology and toxicology of metiamide, a histamine H2-receptor antagonist.
D000818:Animals; D002217:Carbachol / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004386:Duodenum; D005260:Female; D005750:Gastric Juice / Q000378:metabolism; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology; D007263:Infusions, Parenteral; D007441:Intubation, Gastrointestinal; D008297:Male; D051379:Mice; D010215:Papio; D010418:Pentagastrin / Q000037:antagonists & inhibitors; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012636:Secretory Rate / Q000187:drug effects; D013440:Sulfides / Q000008:administration & dosage / Q000494:pharmacology; D013890:Thiourea / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology
D006634:Histamine H1 Antagonists; D007093:Imidazoles; D011955:Receptors, Drug; D013440:Sulfides; D002217:Carbachol; D010418:Pentagastrin; D013890:Thiourea